CDKN2A and neoplasm: To assess the effects of FdCyd on the epigenetic regulation of p16, we also assessed tumor promoter methylation of the p16-encoding gene CDKN2A, as measured in our genome-wide promoter hypomethylation analysis of tumor biopsy cores.